The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Amyloid β-peptide (1-42)-induced Oxidative Stress and Neurotoxicity: Implications for Neurodegeneration in Alzheimer's Disease Brain. A Review
Abstract
Oxidative stress, manifested by protein oxidation, lipid peroxidation, DNA oxidation and 3-nitrotyrosine formation, among other indices, is observed in Alzheimer's disease (AD) brain. Amyloid beta-peptide (1-42) [Abeta(1-42)] may be central to the pathogenesis of AD. Our laboratory and others have implicated Abeta(1-42)-induced free radical oxidative stress in the neurodegeneration observed in AD brain. This paper reviews some of these studies from our laboratory. Recently, we showed both in-vitro and in-vivo that methionine residue 35 (Met-35) of Abeta(1-42) was critical to its oxidative stress and neurotoxic properties. Because the C-terminal region of Abeta(1-42) is helical, and invoking the i + 4 rule of helices, we hypothesized that the carboxyl oxygen of lle-31, known to be within a van der Waals distance of the S atom of Met-35, would interact with the latter. This interaction could alter the susceptibility for oxidation of Met-35, i.e. free radical formation. Consistent with this hypothesis, substitution of lle-31 by the helix-breaking amino acid, proline, completely abrogated the oxidative stress and neurotoxic properties of Abeta(1-42). Removal of the Met-35 residue from the lipid bilayer by substitution of the negatively charged Asp for Gly-37 abrogated oxidative stress and neurotoxic properties of Abeta(1-42). The free radical scavenger vitamin E prevented A(beta (1-42)-induced ROS formation, protein oxidation, lipid peroxidation, and neurotoxicity in hippocampal neurons, consistent with our model for Abeta-associated free radical oxidative stress induced neurodegeneration in AD. ApoE, allele 4, is a risk factor for AD. Synaptosomes from apoE knock-out mice are more vulnerable to Abeta-induced oxidative stress (protein oxidation, lipid peroxidation, and ROS generation) than are those from wild-type mice. We also studied synaptosomes from allele-specific human apoE knock-in mice. Brain membranes from human apoE4 mice have greater vulnerability to Abeta(1-42)-induced oxidative stress than brain membranes from apoE2 or E3, assessed by the same indices, consistent with the notion of a coupling of the oxidative environment in AD brain and increased risk of developing this disorder. Using immunoprecipitation of proteins from AD and control brain obtained no longer than 4h PMI, selective oxidized proteins were identified in the AD brain. Creatine kinase (CK) and beta-actin have increased carbonyl groups, an index of protein oxidation, and Glt-1, the principal glutamate transporter, has increased binding of the lipid peroxidation product, 4-hydroxy-2-nonenal (HNE). Abeta inhibits CK and causes lipid peroxidation, leading to HNE formation. Implications of these findings relate to decreased energy utilization, altered assembly of cytoskeletal proteins, and increased excitotoxicity to neurons by glutamate, all reported for AD. Other oxidatively modified proteins have been identified in AD brain by proteomics analysis, and these oxidatively-modified proteins may be related to increased excitotoxicity (glutamine synthetase), aberrant proteasomal degradation of damaged or aggregated proteins (ubiquitin C-terminal hydrolase L-1), altered energy production (alpha-enolase), and diminished growth cone elongation and directionality (dihydropyrimindase-related protein 2). Taken together, these studies outlined above suggest that Met-35 is key to the oxidative stress and neurotoxic properties of Abeta(1-42) and may help explain the apoE allele dependence on risk for AD, some of the functional and structural alterations in AD brain, and strongly support a causative role of Abeta(1-42)-induced oxidative stress and neurodegeneration in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oxidative stress and mitochondrial dysfunction are prominent features of many neurodegenerative diseases including AD (Butterfield, 2002; Butterfield and Boyd-Kimball, 2018; Sharma and Kim, 2021).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Butterfield, 2002
In the citing paper
“For the same reason, the Aβ insertion into the lipid bilayer of the neuronal plasma membrane induces lipid peroxidation in a direct manner (Butterfield, 2002).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Butterfield, 2002
Citations
Cites
Free radicals in biology and medicine
Gutteridge, J. M. C. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,017
Impaired Proteasome Function in Alzheimer's Disease
Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848
Mark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010255.x · Cited by 783
Cited by
Sorted by citations
Items 601–700 of 794
New access to Alzheimer’s and other neurodegenerative diseases
Hamacher, M., Meyer, H. E., & Marcus, K. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.5.591 · Cited by 6
Naik, N., Kumar, H. V., Dias, S. M., & Jagadish, S. (2013) · MyPrints@UOM (Mysore University Library) · Cited by 6
Rajak, P., Ganguly, A., & Nanda, S. (2025) · Green Analytical Chemistry · doi:10.1016/j.greeac.2025.100228 · Cited by 5
Abduljawad, A. A., Alkinani, K. B., Zaakan, A., AlGhamdi, A. S., Hamdoon, A. A. E., Alshanbari, B. H., Alshehri, A. A., Alluhaybi, B. B., Alqashi, S. O. I., & Abduljawad, R. A. (2025) · Pharmaceuticals · doi:10.3390/ph18111731 · Cited by 7
Gharandouq, M. H., Ismail, M. A., Saleh, T., Zihlif, M., & Ababneh, N. A. (2025) · Neurotoxicity Research · doi:10.1007/s12640-025-00734-6 · Cited by 5
Ed‐Dahmani, I., fadili, M. E., Nouioura, G., Atki, Y. E., Kandsi, F., Conte, R., Lafdil, F. Z., Mssillou, I., Al‐Sheikh, Y. A., Aboul‐Soud, M. A. M., et al. (2024) · ChemistrySelect · doi:10.1002/slct.202403973 · Cited by 5
Chaturvedi, A. (2015) · Asian journal of biomedical and pharmaceutical sciences · doi:10.15272/ajbps.v5i44.688 · Cited by 5
Wu, Q., Li, F., Guo, H.-Y., Cao, J., Chen, C., Chen, W., Zeng, L.-Y., Li, Z., Wang, X., & Xu, K. (2012) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2012.12.034 · Cited by 5
Mak, A. M., Whiteman, M., & Wong, M. W. (2007) · The Journal of Physical Chemistry A · doi:10.1021/jp073142p · Cited by 5
Morozov, A. V., Yurinskaya, M. M., Mitkevich, V. A., Garbuz, D. G., Преображенская, О. В., Винокуров, М. Г., Evgen’ev, M. B., Карпов, В. Л., & Makarov, A. А. (2017) · Molecular Biology · doi:10.1134/s0026893316060133 · Cited by 5
The first observation of electrochemistry of graphene/cysteine/copper composite
Nioradze, N., Dolidze, T. D., Shushanyan, M., & Khoshtariya, D. E. (2019) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2019.113490 · Cited by 5
[Oxidative stress and Alzheimer's disease].
Liu, X., Yang, W., & Qi, J. (2012) · PubMed · Cited by 5
Bambole, A. N., Meena, S. N., Nandre, V., & Kodam, K. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15232-0.00008-4 · Cited by 5
Lipids in Alzheimer’s Disease Brain
Butterfield, D. A., & Abdul, H. M. (2009) · Springer eBooks · doi:10.1007/978-0-387-30378-9_22 · Cited by 5
Good, C. J., Bowman, A. P., Klein, C., Awwad, K., Buck, W. R., Yang, J., & Wagner, D. S. (2025) · Journal of Mass Spectrometry · doi:10.1002/jms.5161 · Cited by 5
Nguyen, H. V. M., Ran, Q., Salmon, A. B., Ahn, B., Chiao, Y. A., Bhaskaran, S., & Richardson, A. G. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.10.269 · Cited by 4
Shome, A., Jha, K. T., Chahat, Chawla, V., & Chawla, P. A. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273315191241002115155 · Cited by 4
Metabolomics in the Study of Alzheimer's Disease
Ibáñez, C., Valdés, A., García‐Cañas, V., & Simó, C. (2014) · Comprehensive analytical chemistry · doi:10.1016/b978-0-444-62650-9.00010-5 · Cited by 4
Antioxidants and Neuroprotection
Antoniou, X., Borsello, T., Lüscher, T. F., & Camici, G. G. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_94 · Cited by 4
Mamun, A. A. (2015) · Medical Entomology and Zoology · Cited by 4
Amyloid β-Peptide(1-42), Oxidative Stress, and Alzheimer’s Disease
Butterfield, D. A. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_5 · Cited by 4
Grandi, V., Milanesi, N., Sessa, M., Gola, M., Cappugi, P., & Pimpinelli, N. (2019) · Giornale Italiano di Dermatologia e Venereologia · doi:10.23736/s0392-0488.17.05603-6 · Cited by 4
Yamaji, Y., Wakabayashi, T., & Kofujita, H. (2020) · Journal of Wood Science · doi:10.1186/s10086-020-01923-x · Cited by 4
Neuropharmacological Properties of Marine Plants
Cho, S., & Kim, S. (2012) · CRC Press eBooks · doi:10.1201/b13868-31 · Cited by 4
Berhanu, W. M., & Masunov, A. E. (2013) · Polyphenols in Human Health and Disease · doi:10.1016/b978-0-12-398456-2.00006-2 · Cited by 4
Abdel‐Salam, O. M. E., Mohammed, N. A., Morsy, S., Youness, E. R., Omara, E. A. A., & Sleem, A. A. (2012) · Comparative Clinical Pathology · doi:10.1007/s00580-012-1656-6 · Cited by 4
NEUROPROTECTIVE EFFECTS OF SULFATED POLYSACCHARIDES FROM SEAWEED
Besednova, N. N., Lomova, L. M., Гуляев, С. А., & Zaporozhets, T. S. (2013) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn.v68i5.663 · Cited by 4
Calcium and redox homeostasis in Alzheimer's disease: a focus on the endoplasmic reticulum
(2015) · Therapeutic Targets for Neurological Diseases · doi:10.14800/ttnd.428 · Cited by 4
Membrane‐targeted strategies for modulating APP and Aβ‐mediated toxicity
Price, K. A., Crouch, P. J., Donnelly, P. S., Masters, C. L., White, A. R., & Curtain, C. C. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00642.x · Cited by 4
Through space interaction between ferrocenes mediated by a thioether
Meyer, G. J., Hall, G. B., Smith, E. R., Sakamoto, T., Lichtenberger, D. L., & Glass, R. S. (2014) · Polyhedron · doi:10.1016/j.poly.2014.06.050 · Cited by 4
Neuropharmacological Properties of Marine Plants
Kim, S. (2012) · Cited by 4
Childers, W. S., Mehta, A. K., Bui, T. Q., & Liang, Y. (2012) · doi:10.1201/b13982-3 · Cited by 4
Brain Protein Oxidation and Modification for Good or for Bad in Alzheimer’s Disease
Rukhsana Sultana, A., & Butterfield, D. A. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_17 · Cited by 4
Designing Novel Peptidic Inhibitors of Beta Amyloid Oligomerization
Roy, S. S. (2010) · Libraries and Cultural Resources (University of Calgary) · doi:10.5072/prism/17548 · Cited by 4
Varshavskaya, K. B., Barykin, E. P., Timoshenko, R. V., Колмогоров, В., Erofeev, A. S., Gorelkin, P. V., Mitkevich, V. A., & Makarov, A. А. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1501874 · Cited by 3
Cristea, S., Perisoara, A., Tihăuan, B.-M., Ene, M. D., Constantin, M., Florea, M.-A., Ivan, E. Ş., Zală, C. R., Purcăreanu, B., Mihăiescu, D. E., et al. (2025) · Plants · doi:10.3390/plants14213320 · Cited by 3
Butterfield, D. A. (2004) · Springer eBooks · doi:10.1007/978-1-4419-8959-8_14 · Cited by 3
An Update on Neuroaging on Earth and in Spaceflight
Kuznetsov, N. V., Statsenko, Y. A., & Ljubisavljević, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041738 · Cited by 6
Tzekaki, E. E., Katsipis, G., Chatzikostopoulos, A., Koutoupa, A., Lavrentiadou, S. N., Tsolaki, M., & Pantazaki, Α. A. (2025) · Biology · doi:10.3390/biology14050548 · Cited by 4
Ko, K. M., Leong, P. K., Lam, P. Y., & Chen, N. (2014) · The Open Nutraceuticals Journal · doi:10.2174/1876396001407010049 · Cited by 3
NEUROPROTECTIVE EFFECTS OF THE LIPIDIC EXTRACT FROM INTEGUMENT OF SQUID DOSIDICUS GIGAS
Hwang, P.-A., Tsai, Y.-G., Gau, S.-Y., Hung, Y.-L., & Fan, C.-C. (2011) · Journal of marine science and technology · doi:10.51400/2709-6998.2142 · Cited by 3
Natural Antioxidants to the Rescue?
Aydın, C., & Seyidoğlu, N. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96132 · Cited by 3
Oxidative Stress: A Double Edged Sword
Saldera, K. A., Samo, U. B. K., Memon, A. S., & Soomro, S. (2021) · BioSight · doi:10.46568/bios.v2i1.40 · Cited by 3
Clinical role of oxides in Neuropsychiatric and Neurodegenerative disorders
Arora, R., Kumar, A., Gupta, R., & Maurya, P. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90538-1.00011-x · Cited by 3
Morozov, A. V., Burov, A. V., Funikov, S. Y., Teterina, E. V., Astakhova, T. M., Erokhov, P. A., Ustyugov, A. A., & Карпов, В. Л. (2023) · Molecular Biology · doi:10.1134/s0026893323050138 · Cited by 3
Piccialli, I., Greco, F., Roviello, G. N., Sisalli, M. J., Tedeschi, V., Mola, A. D., Borbone, N., Oliviero, G., Feo, V. D., Secondo, A., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115745 · Cited by 3
Mihaylova, R., Zheleva‐Dimitrova, D., Elincheva, V., Gevrenova, R., Momekov, G., & Simeonova, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189805 · Cited by 3
Wan, S.-C., Wang, S., Zhang, X., Li, H., Sun, M., Chen, G., Wang, J., & Li, X. (2025) · Neurological Sciences · doi:10.1007/s10072-024-07976-w · Cited by 3
Selenium-Functionalized Molecules (SeFMs) as Potential Drugs and Nutritional Supplements
Abdur, R., & Huang, Z. (2015) · Topics in medicinal chemistry · doi:10.1007/7355_2015_87 · Cited by 3
Yoo, S. K., Kim, J. M., Lee, U., Kang, J.-Y., Park, S.-K., Han, H.-J., Park, H.-W., Kim, H., Kim, C. W., Kim, M.-J., et al. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb43010033 · Cited by 3
Shea, T. B. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.039 · Cited by 3
Rukhsana Sultana, A., Robinson, R. A. S., & Butterfield, D. A. (2009) · Contemporary clinical neuroscience · doi:10.1007/978-1-60327-342-8_9 · Cited by 3
Protective Effect of Anthocyanin Against The Oxidative Stress in Neuroblastoma N2a Cells*
Liu, L., Sheng, B., Yan, Y., Gong, K., Ma, T., Zhao, N., Zhang, X., & Gong, Y. (2010) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2009.00773 · Cited by 3
Néri, T., Bucciantini, M., Rosti, V., Raimondi, S., Relini, A., Massa, M., Zuccotti, M., Donadei, S., Stefani, M., Redi, C. A., et al. (2010) · Amyloid · doi:10.3109/13506129.2010.530138 · Cited by 3
Oxidative Stress in Alzheimer's Disease: Targeting with Nanotechnology
Behera, R. K., Goel, S., Domann, N., Mahapatra, A., Hosmane, N. S., Evans, T., & Das, B. C. (2014) · Cited by 3
Lee, E. H., Youn, Y. C., Park, K., Min, J. H., Kwon, O. S., Lee, H. O., & Hong, H. J. (2008) · Journal of the Korean Neurological Association · Cited by 3
Methionine 35 sulphoxide reduces toxicity of Aβ in red blood cell
Carelli‐Alinovi, C., & Misiti, F. (2017) · European Journal of Clinical Investigation · doi:10.1111/eci.12735 · Cited by 3
Tenório, T. D. S., & Tenório, A. (2015) · Vibrational Spectroscopy · doi:10.1016/j.vibspec.2015.06.005 · Cited by 3
Glutamate Receptors and Neurological Disorders
Farooqui, A. A., Ong, W., & Horrocks, L. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-73023-3_8 · Cited by 3
The Role of Periodontitis in Increasing Cognitive Decline in Alzheimer\'s Disease
Freitas, C. M. T., Patil, S., Klonaris, N., & Murcia, J. D. G. (2025) · The Journal of Contemporary Dental Practice · doi:10.5005/jp-journals-10024-3847 · Cited by 2
Akar, S., Alvur, Ö., Evyapan, G., Özdem, B., & Doru, İ. P. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70903 · Cited by 2
DNA barcoding and antioxidant study of four Dendrobium species found in Manipur
Sunanda, Y., Bhardwaj, A. R., Mikawlrawng, K., Pandey, R. K., & Sarangthem, K. (2022) · Vegetos · doi:10.1007/s42535-022-00517-w · Cited by 2
Sen, S., Meur, S., Nandi, G., & Karati, D. (2024) · Brain Disorders · doi:10.1016/j.dscb.2024.100171 · Cited by 2
Treatment of Alzheimer's disease
Sano, M. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.033 · Cited by 2
An update on using vitamin E in Alzheimer's disease
Kontush, A., & Schekatolina, S. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.2.261 · Cited by 2
Experimental and theoretical investigation of [Al(PCr)(H2O)] complex in aqueous solution
Tenório, T. D. S., Lopes, D. C. N., Silva, A. M., Ramos, J. M., & Buarque, C. D. (2013) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2013.08.073 · Cited by 2
Selenium in Alzheimer’s Disease
Bellinger, F. P., & Weeber, E. J. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1025-6_34 · Cited by 2
Aging: Thromboembolic Disease, Metabolic Syndrome, Type 2 Diabetes Mellitus, and Alzheimer’s Disease
Lasierra-Cirujeda, J., Pascual-Salcedo, M. J. A., Lasierra-Ibañez, A., AZA, C. L., & Aza‐Pascual‐Salcedo, M. (2016) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2016.45001 · Cited by 3
Doungue, H. T., Kengne, A. P. N., & Womeni, H. M. (2020) · Food and Nutrition Sciences · doi:10.4236/fns.2020.115029 · Cited by 2
Proteasome activity modulates amyloid toxicity
Galvin, J., Curran, E., Arteaga, F., Goossens, A., Aubuchon-Endsley, N., McMurray, M. A., Moore, J., Hansen, K. C., Chial, H. J., Potter, H., et al. (2022) · FEMS Yeast Research · doi:10.1093/femsyr/foac004 · Cited by 2
Childers, W. S., Mehta, A., Bui, T. Q., Liang, Y., & Lynn, D. G. (2012) · Pan Stanford Publishing eBooks · doi:10.1201/b13982-2 · Cited by 2
Stress oxydant et maladie d’Alzheimer
Gilbert, T., Drai, J., & Bonnefoy, M. (2013) · Springer eBooks · doi:10.1007/978-2-8178-0443-9_10 · Cited by 2
Mitochondrial and Chloroplastic Targeting Peptides Peptidase, PreP
Glaser, E. G., Kmiec, B., & Teixeira, P. F. (2012) · Handbook of Proteolytic Enzymes · doi:10.1016/b978-0-12-382219-2.00321-5 · Cited by 2
Şahin, S., & Mazı, I. B. (2011) · Wiley eBooks · doi:10.1002/9781444355321.ch17 · Cited by 2
Rukhsana Sultana, A., Reed, T. T., & Butterfield, D. A. (2008) · Wiley eBooks · doi:10.1002/9783527622467.ch9 · Cited by 2
Althobaiti, N. A., Albalawi, A. E., Warnock, N. D., Mccammick, E. M., Alsolais, A., Alkhaibari, A. M., Al-Hazani, T. M. I., Menaa, F., Dalzell, J. J., & Green, B. D. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.05.020 · Cited by 2
RetractedN’Go, P. K., Tehoua, L., Ahami, O. T. A., Azzaoui, F.-Z., & Aboussaleh, Y. (2021) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2220 · Cited by 2
Antioxidant and Acetylcholinesterase Inhibitor Potentials of the Stem Extract of Pternandra galeata
Suciati, S., Inayah, D. N., Widyawaruyanti, A., & Rudiyansyah, R. (2022) · Revista Vitae · doi:10.17533/udea.vitae.v29n3a349983 · Cited by 1
Salivary biomarkers for neurodegenerative disorder for biomedical sensing
Singhal, A., Devi, R., Parihar, A., & Khan, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95539-3.00011-9 · Cited by 1
On the Photosensitizer Activity From Psoralen in Lipid and Aqueous Media: A Theoretical Study
Couttolenc, A., Jerezano, A. V., Espinoza, C., & Medina, M. E. (2024) · Journal of Physical Organic Chemistry · doi:10.1002/poc.4672 · Cited by 1
Unlocking the therapeutic promise of miRNAs in promoting amyloid-β clearance for Alzheimer's disease
Kaur, V., & Sunkaria, A. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115505 · Cited by 1
Fusi, G., Colombo, B., & Caravita, S. C. S. (2026) · Wiley Interdisciplinary Reviews Cognitive Science · doi:10.1002/wcs.70038 · Cited by 1
Redox Chemistry of Sulfur, Selenium and Tellurium Compounds
Glass, R. S. (2011) · Springer eBooks · doi:10.1007/978-3-642-20699-3_3 · Cited by 1
Circulating free nitrotyrosine and cognitive decline
Coppola, L., Pastore, A., Adamo, G., Coppola, A., Manzella, D., Gombos, I. K., Luongo, M., & Mastrolorenzo, L. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01286.x · Cited by 1
Zawia, N. H., & Cardozo‐Pelaez, F. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-602-3_22 · Cited by 1
Magnetite Mechanisms in Alzheimer's Disease
Li, Y., Pan, W., & Song, T. (2011) · Acta Biophysica Sinica · doi:10.3724/sp.j.1260.2011.00121 · Cited by 1
Acetyl-l-Carnitine and Ferulic Acid Action in Aging and Neurodegenerative Diseases
Butterfield, D. A., Sowell, A., Renã, & Aluise, C. D. (2009) · Oxidative stress and disease · doi:10.1201/9781420073522.ch23 · Cited by 1
NEW MARKERS OF OXIDATIVE DAMAGE TO MACROMOLECULES
Oksidativnog, N. M., Makromolekula, O. E., & olak, E. (2008) · Cited by 1
Rapid cognitive decline and myoclonus in a 52-year-old woman
Gravley, W., Murphy, C. J., Kang, C.-D., & Hanif, B. (2021) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.88a.20004 · Cited by 1
Methylmercury and Alzheimer’s Disease
Nabi, S. (2014) · Springer eBooks · doi:10.1007/978-81-322-1922-4_26 · Cited by 1
Neuroprotective strategies in Alzheimer’s disease
Longo, F. M., & Massa, S. M. (2004) · Neurotherapeutics · doi:10.1007/bf03206572 · Cited by 1
Role of oxidative stress in Alzheimer's disease and related consequences
Chmátalová, Z., & Skoumalová, A. (2014) · Klinická biochemie a metabolismus · doi:10.61568/kbm.2014.031 · Cited by 1
Behavioral Methods Used in the Study of Learning and Memory
Hall, F. S., & Saber, Y. (2015) · Springer eBooks · doi:10.1007/978-3-642-27728-3_37-1 · Cited by 1
Growth Hormone and Insulin-like Growth Factor-I in Alzheimer's Disease
Gómez, J. M. (2006) · Elsevier eBooks · doi:10.1016/b978-012088484-1/50026-4 · Cited by 1
Mecanismos reparadores neuronales en la enfermedad de Alzheimer
Urdaneta, E., Barrenetxe, J., de Mera, R. M. M. F., & Jordán, J. (2006) · Revista Española de Geriatría y Gerontología · doi:10.1016/s0211-139x(06)73011-6 · Cited by 1
Kang, S. G., & Seong, Y. H. (2018) · Journal of Biomedical Translational Research · doi:10.12729/jbtr.2018.19.2.026 · Cited by 1
Polyphenols and their antioxidant and nonantioxidant effects in health and disease
Duttaroy, A. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822405-2.00030-x · Cited by 1
Physiologic and Neurotoxic Properties of Aβ Peptides
Gregory, G. C., Shepherd, C. E., & Halliday, G. M. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_11 · Cited by 1
Suciati, S., Rizqiyah, W., Inayah, D. N., Widyowati, R., Ekasari, W., & Suphrom, N. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00293 · Cited by 1
Carnitine Acetyltransferase and Mitochondrial Acetyl-CoA Buffering in Exercise and Metabolic Disease
Hogan, S. S. (2013) · DukeSpace (Duke University) · Cited by 1
Metadata
- Authors
- Allan Butterfield, D.
- Venue
- Free Radical Research
- Publisher
- Informa UK Limited
- Published
- 2002-01
- Volume
- 36
- Issue
- 12
- Pages
- 1307-1313
- ISSN
- 1029-2470 (ISSN-L)
- 1071-5762
- OpenAlex
- W2153767421
- Cited by
- 786
- References
- 58
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 18 · 2023: 21 · 2022: 24 · 2021: 34 · 2020: 26 · 2019: 28 · 2018: 30 · 2017: 32 · 2016: 45 · 2015: 43 · 2014: 42 · 2013: 39 · 2012: 42
- FWCI
- 18.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Free Radical Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Kentucky
- National Institute on Aging (P01AG010836, P01AG005119, AG 10836, AG12423, AG0 5119, R01AG012423)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid beta peptide 1-42, oxidative stress, neurotoxicity, Alzheimer's disease, protein oxidation, lipid peroxidation, nitrotyrosine, vitamin E, hippocampal neurons, synaptosomes, apolipoprotein E, APOE ε4, amyloid fibril formation, neurodegeneration, lipid bilayers
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Animals, Brain, Humans, Lipid Bilayers, Methionine, Molecular Sequence Data, Neurons, Peptide Fragments, Peptides, Free Radical Scavengers, Amyloid beta-Peptides, Reactive Oxygen Species, Protein Structure, Tertiary, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review